NCT06414837View on ClinicalTrials.gov

Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

434

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Gout With Hyperuricemia in Adults
Interventions
DRUG

HR091506 tablets + placebo of febuxostat tablets

HR091506 tablets 20mg/ 40mg/ 60mg/80mg qd + placebo of febuxostat tablets 20mg/ 40mg/ 60mg/80mg qd, from Week 1 to 36.

DRUG

febuxostat tablets + placebo of HR091506 tablets

febuxostat tablets 20mg/ 40mg/ 60mg/80mg qd + placebo of HR091506 tablets 20mg/ 40mg/ 60mg/80mg qd . from Week 1 to 36.

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY